Wikipedia

Dan Riskin

This article is about the physician and entrepreneur. For the biologist and television host, see Daniel K. Riskin.

Dan Riskin is an American entrepreneur and surgeon.[1] As an expert in healthcare artificial intelligence, Riskin has promoted healthcare quality improvement and helped shape policy in the US and globally.[2][3] Riskin's companies, featured in Forbes and The Wall Street Journal, have influenced the care of millions of patients.[4] He continues to practice, teach, and perform research as Clinical Professor of Surgery at Stanford University.[5]

Dan Riskin
Dan Riskin, American entrepreneur and CEO of Verantos
Born (1971-10-15) October 15, 1971 (age 52)
Los Angeles, California
Alma mater

Early life and education edit

Riskin was born on October 15, 1971, and grew up in Los Angeles, California. He began writing software at age 5, selling software at age 12, and winning regional awards in software programming during grammar school.[6] As a teenager, Riskin studied at Brentwood High School, where he received the Bausch and Lomb Outstanding Scientist Award. He began college at age 16 as a Regent’s Scholar at University of California.[7] He received a medical degree from Boston University and completed surgery residency at University of California, Los Angeles and a critical care and acute care surgery fellowship at Stanford University. He earned a MBA with focus in bioinformatics and bioengineering at the Massachusetts Institute of Technology.[8] Upon completion of his training in 2008, Riskin was promoted to Consulting Assistant Professor of Surgery at Stanford University.[9]

Business edit

While a student at MIT and Stanford in 2005, Riskin designed a painless wound closure device for which he later was issued US patents and FDA approval.[10] Riskin cofounded Wadsworth Medical Technologies, which commercialized the product under the Dermaloc brand. The company was acquired by DQ Holdings and the product was rebranded DermaClip for sales in the US and China.[11] The product has been used successfully on hundreds of thousands of patients.[12]

In 2011, Riskin founded and became CEO of Health Fidelity, a company which implements artificial intelligence to measure clinical quality and risk for value-based healthcare. As CEO, Riskin secured relationships with Harvard, Children’s Hospital of Philadelphia, and University of Pittsburgh Medical Center. He grew the company through three financing rounds.[13] Health Fidelity was acquired by Edifecs in a transaction valued in excess of $150 million.[14]

In 2015, Riskin founded and became CEO of Verantos, a company which applies artificial intelligence to newly available health data to generate high-validity real-world evidence, which uses clinical experience across millions of patients to offer insight into what treatments will work best for whom. Riskin was funded to pursue high-validity real-world evidence by the National Institutes of Health starting in 2015, the National Science Foundation in 2018, and the Food and Drug Administration in 2020.[15][16][17] Verantos names multiple top 10 life sciences firms as customers. The company was recognized as Bioinformatics Company of the Year in 2021 and was subsequently recognized by Inc 5000 and Deloitte Fast 500 as one of America's fastest growing private companies.

Policy and public service edit

Riskin has advocated a bipartisan approach to leverage clinical data to improve US healthcare quality. He described two decades of health data reform. The first, from 2010 - 2020, would institute electronic data capture and enable value-based healthcare. The second decade, from 2020 - 2030, would leverage the massive amounts of collected data to tailor therapy and enable personalized medicine.

Focusing on the first decade of healthcare data reform, capturing electronic information and improving value-based workflow, Riskin promoted a transition to electronic health records and use of data to improve care within the Obama Campaign Healthcare Advisory Committee starting in 2007. These efforts were enacted through the HITECH Act in 2009 and Affordable Care Act in 2010. Riskin's academic work "Re-examining health IT policy: What will it take to derive value from our investment?" encouraged national discussion on innovation and analytics.[18] He founded and built a company, Health Fidelity, with a vision to capture accurate electronic information and improve value-based workflow.[19]

Focusing on the second decade of healthcare data reform, tailoring therapy based on real world evidence, Riskin provided Congressional testimony in the 21st Century Cures Initiative in 2014.[20] He met in Congressional retreat to help refine the bill in 2015.[21] The 21st Century Cures Act, passed in December 2016, included a pathway to incorporate real-world evidence into regulatory decision-making. Riskin's academic work "Real world evidence in cardiovascular medicine: ensuring data validity in electronic health record-based studies" described an approach to use advanced technology and data to enable credible real-world evidence.[22] He founded and built a company, Verantos, with a vision to refine the standard of care based on real-world evidence.[23]

Riskin has continued to focus national attention on healthcare quality through the HHS Quality Measurement Task Force,[24] in Centers for Medicare and Medicaid Services Grand Rounds,[25] in FDA Grand Rounds and workshops,[26] as a Congressionally-appointed member of the US Health IT Advisory Committee,[27] and through academic publication.

References edit

  1. ^ MIT Technology Review. ""MIT Technology Review", MIT Technology Review, 2005". MIT Technology Review. Retrieved August 2, 2014.
  2. ^ "21st Century Technology for 21st Century Cures - Energy and Commerce Committee". Energy and Commerce Committee. Archived from the original on 2018-02-07. Retrieved 2018-02-07.
  3. ^ "Taiwan Government Health Seminar". archive.eettaiwan.com. Retrieved 2018-02-07.
  4. ^ "The Next Revolution in Healthcare". Forbes. Retrieved 2016-12-06.;Hay, Timothy. "Digging Into the Crucial Info Buried in Medical Data". The Wall Street Journal. Retrieved 2017-01-14.;"Big data: opportunity and challenge". Healthcare IT News. 2012-06-12. Retrieved 2016-12-06.
  5. ^ "Dan Riskin's Profile | Stanford Profiles". profiles.stanford.edu. Retrieved 2024-02-02.
  6. ^ ""Health Grades", Awards". Healthgrades.com. Retrieved January 26, 2012.
  7. ^ "Dan Riskin". LinkedIn.
  8. ^ "Stanford Biodesign Alumni Fellows". Stanford Byers Center for Biodesign. Retrieved 2 August 2014.
  9. ^ "Public View of Stanford People Search". stanfordwho.stanford.edu. Archived from the original on 2017-03-14. Retrieved 2017-01-27.
  10. ^ Riskin, Daniel J.; Fox, Andrew D.; Barenboym, Michael (April 17, 2012), United States Patent: 8157839 - Systems and methods for closing a tissue opening, retrieved August 29, 2022
  11. ^ "DQ Holdings, LLC - DermaClip, L.L.C." www.dqholdings.com. Retrieved 2017-01-27.
  12. ^ "Xconomy: DermaClip Ramps Up for U.S. Sales Push of Wound-Healing Device". Xconomy. 2019-01-23. Retrieved 2019-09-03.
  13. ^ "Health Fidelity REVEAL Improves Information Exchange by Extracting Value from Unstructured Clinical Data". EMR Daily News. 2012-04-26. Archived from the original on 2017-02-02. Retrieved 2017-01-27.;"Health Fidelity Receives NSF Grant to Support Big Data Research". HITECH Answers. 2013-02-20. Archived from the original on 2017-02-02. Retrieved 2017-01-27.;PR Newswire. "Health Fidelity Closes Series A Financing Round". Retrieved February 26, 2015.;"UPMC Makes Strategic Investment in Health Fidelity to Develop Technologies that Advance Value-Based Healthcare". www.prnewswire.com. Retrieved 2016-11-06.
  14. ^ "Edifecs completes acquisition of Health Fidelity". Healthcare IT News. 2021-12-21. Retrieved 2023-08-15.
  15. ^ "Project Information - NIH RePORTER - NIH Research Portfolio Online Reporting Tools Expenditures and Results". projectreporter.nih.gov. Retrieved 2016-10-09.;"Project Information - NIH RePORTER - NIH Research Portfolio Online Reporting Tools Expenditures and Results". projectreporter.nih.gov. Retrieved 2016-10-09.
  16. ^ "NSF Award Search: Award#1819388 - SBIR Phase I: Determination of complex outcome measures using narrative clinical data to enable observational trials". www.nsf.gov. Retrieved 2019-09-03.
  17. ^ Verantos. "Verantos Receives FDA Support to Demonstrate Advanced Approaches to Real-World Evidence". www.prnewswire.com. Retrieved 2023-08-15.
  18. ^ Riskin, Loren; Koppel, Ross; Riskin, Daniel (2015-03-01). "Re-examining health IT policy: what will it take to derive value from our investment?". Journal of the American Medical Informatics Association. 22 (2): 459–464. doi:10.1136/amiajnl-2014-003065. ISSN 1527-974X. PMID 25326600.
  19. ^ "Health Fidelity | NLP-Enabled Risk Adjustment Technology". Health Fidelity, Inc. Retrieved 2019-09-03.
  20. ^ ""21st Century Technology for 21st Century Cures", Joint hearing of the Subcommittee on Healthcare and the Subcommittee on Communications and Technology, July 17, 2014". Archived from the original on August 8, 2014. Retrieved August 2, 2014.
  21. ^ "Bipartisan Congressional Health Policy Conference" (PDF). The Commonwealth Fund. February 20, 2015. Archived from the original (PDF) on January 5, 2017. Retrieved December 6, 2016.
  22. ^ Riskin, Dan; Crespo, Blai Coll; Monda, Keri L.; Hernandez-Boussard, Tina (2019). "Real world evidence in cardiovascular medicine: assuring data validity in electronic health record-based studies". Journal of the American Medical Informatics Association. 26 (11): 1189–1194. doi:10.1093/jamia/ocz119. PMC 6798570. PMID 31414700.
  23. ^ "Home". Verantos. Retrieved 2019-09-03.
  24. ^ "Quality Measurement Task Force FACA". www.healthit.gov. Department of Health and Human Services. Archived from the original on 2016-11-06. Retrieved 2016-12-06.
  25. ^ "Innovation and Data in Healthcare" (PDF). www.cms.gov. Centers for Medicare and Medicaid Services (CMS). April 8, 2015. Retrieved December 6, 2016.
  26. ^ "Unpacking Real-World Data Curation: Principles and Best Practices to Support Transparency and Quality | Margolis Center for Health Policy". healthpolicy.duke.edu. Retrieved 2019-09-03.
  27. ^ "HITAC Membership | HealthIT.gov". www.healthit.gov. Retrieved 2024-02-02.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Dan_Riskin&oldid=1215888655"